{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T22:44:53Z","timestamp":1772577893871,"version":"3.50.1"},"reference-count":21,"publisher":"Japan Endocrine Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1507\/endocrj.ej19-0035","type":"journal-article","created":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T18:02:51Z","timestamp":1560276171000},"page":"853-857","source":"Crossref","is-referenced-by-count":23,"title":["Acromegaly caused by a somatotroph adenoma in patient with neurofibromatosis type 1"],"prefix":"10.1507","volume":"66","author":[{"given":"Kaori","family":"Hozumi","sequence":"first","affiliation":[{"name":"Division of Diabetes and Endocrinology, Kobe University Hospital, Hyogo 650-8511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Fukuoka","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Kobe University Hospital, Hyogo 650-8511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Odake","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Kobe University Graduate School of Medicine, Hyogo 650-8511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehito","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Kobe University Hospital, Hyogo 650-8511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Uehara","sequence":"additional","affiliation":[{"name":"Center for Medical Genetics, Keio University School of Medicine, Tokyo 160-8582, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Keio University School of Medicine, Tokyo 160-8582, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Inoshita","sequence":"additional","affiliation":[{"name":"Department of Pathology, Toranomon Hospital, Tokyo 105-8470, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Kobe University Graduate School of Medicine, Hyogo 650-8511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryusaku","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Kobe University Graduate School of Medicine, Hyogo 650-8511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Bando","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Kobe University Graduate School of Medicine, Hyogo 650-8511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yushi","family":"Hirota","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Kobe University Hospital, Hyogo 650-8511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genzo","family":"Iguchi","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Kobe University Hospital, Hyogo 650-8511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kobe University Graduate School of Medicine, Hyogo 650-8511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Otsuki","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology-Head and Neck Surgery, Kobe University Graduate School of Medicine, Hyogo 650-8511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikako","family":"Nishigori","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Hyogo 650-8511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenjiro","family":"Kosaki","sequence":"additional","affiliation":[{"name":"Center for Medical Genetics, Keio University School of Medicine, Tokyo 160-8582, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonobu","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Keio University School of Medicine, Tokyo 160-8582, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Kobe University Graduate School of Medicine, Hyogo 650-8511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Kobe University Graduate School of Medicine, Hyogo 650-8511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Melmed S (2006) Acromegaly. N Engl J Med 355: 2558\u20132573.","DOI":"10.1056\/NEJMra062453"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Gadelha MR, Kasuki L, Korbonits M (2017) The genetic background of acromegaly. Pituitary 20: 10\u201321.","DOI":"10.1007\/s11102-017-0789-7"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Salpea P, Stratakis CA (2014) Carney complex and McCune Albright syndrome: an overview of clinical manifestations and human molecular genetics. Mol Cell Endocrinol 386: 85\u201391.","DOI":"10.1016\/j.mce.2013.08.022"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 DeBella K, Szudek J, Friedman JM (2000) Use of the national institutes of health criteria for diagnosis of neurofibromatpsis 1 in children. Pediatrics 105: 608\u2013614.","DOI":"10.1542\/peds.105.3.608"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Ratner N, Miller SJ (2015) A RASopathy gene commonly mutated in cancer: the neurofibromatpsis type 1 tumour suppressor. Nat Rev Cancer 15: 290\u2013301.","DOI":"10.1038\/nrc3911"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Bizzarri C, Bottaro G (2015) Endocrine implications of neurofibromatosis 1 in childhood. Horm Res Peadiatr 83: 232\u2013241.","DOI":"10.1159\/000369802"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, et al. (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99: 3933\u20133951.","DOI":"10.1210\/jc.2014-2700"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Nakano S, Sato T, Hosokawa M, Takagi C, Yoshida F, et al. (2018) A pediatric case of insulinoma and anovel <i>MEN1<\/i> mutation: the efficacy of the combination therapy of diazoxide and cornstarch. Clin Pediatr Endocrinol 27: 197\u2013199.","DOI":"10.1297\/cpe.27.197"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Muraoka R, Takenouchi T, Torii C, Shimizu A, Misu K, et al. (2014) The use of next-generation sequencing in molecular diagnosis of neurofibromatosis type 1: a validation study. Genet Test Mol Biomarkers 18: 722\u2013735.","DOI":"10.1089\/gtmb.2014.0109"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10 Odake Y, Fukuoka H, Yamamoto M, Arisaka Y, Konishi J, et al. (2017) Cross-sectional prevalence of pancreatic cystic lesions in patients with acromegaly, a single-center experience. Pituitary 20: 509\u2013514.","DOI":"10.1007\/s11102-017-0810-1"},{"key":"11","unstructured":"11 Costa-Guda J, Marinoni I, Molatore S, Pellegata NS, Arnold A (2011) Somatic mutation and germline sequence abnormalities in CDKN1B, encoding p27Kip1, in sporadic parathyroid adenomas. J Clin Endocrinol Metab 96: E701\u2013E706."},{"key":"12","unstructured":"12 Marques AR, Espadinha C, Catarino AL, Moniz S, Pereira T, et al. (2002) Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas. J Clin Endocrinol Metab 87: 3947\u20133952."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Hegedus B, Yeh TH, Lee DY, Emnett RJ, Li J, et al. (2008) Neurofibromin regulates somatic growth through the hypothalamic-pituitary axis. Hum Mol Genet 17: 2956\u20132966.","DOI":"10.1093\/hmg\/ddn194"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Margraf RL, VanSant-Webb C, Sant D, Carey J, Hanson H, et al. (2017) Utilization of whole-exome next-generation sequencing variant read frequency for detection of lesion-specific, somatic loss of heterozygosity in a neurofibromatosis type 1 cohort with tibial pseudarthrosis. J Mol Diagn 19: 468\u2013474.","DOI":"10.1016\/j.jmoldx.2017.01.008"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Norris EJ, Jones WD, Surleac MD, Petrescu AJ, Destephanis D, et al. (2018) Clonal lineage of high grade serous ovarian cancer in a patient with neurofibromatosis type 1. Gynecol Oncol Rep 23: 41\u201344.","DOI":"10.1016\/j.gore.2018.01.005"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Suarez-Kelly LP, Akagi K, Reeser JW, Samorodnitsky E, Reeder M, et al. (2018) Metaplastic breast cancer in a patient with neurofibromatosis type 1 and somatic loss of heterozygosity. Cold Spring Harb Mol Case Stud 4: pii: a002352.","DOI":"10.1101\/mcs.a002352"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Thomas L, Kluwe L, Chuzhanova N, Mautner V, Upadhyaya M (2010) Analysis of NF1 somatic mutations in cutaneous neurofibromas from patients with high tumor burden. Neurogenetics 11: 391\u2013400.","DOI":"10.1007\/s10048-010-0240-y"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Garcia-Linares C, Fernandez-Rodriguez J, Terribas E, Mercade J, Pros E, et al. (2010) Dissecting loss of heterozygosity (LOH) in neurofibromatosis type 1-associated neurofibromas: importance of copy neutral LOH. Hum Mutat 32: 78\u201390.","DOI":"10.1002\/humu.21387"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Scalzone M, Coccia P, Ruggiero A, Lazzareschi I, Mastrangelo S, et al. (2009) The neurofibromatosis type 1: a dominantly inherited tumors-predisposing disorder. Cent Eur J Med 4: 11\u201316.","DOI":"10.2478\/s11536-009-0013-x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Ishihara M, Iihara M, Okamoto T, Obara T (2007) Water-clear cell parathyroid adenoma causing primary hyperparathyroidism in a patient with neurofibromatosis type 1: report of a case. Surg Today 37: 884\u2013887.","DOI":"10.1007\/s00595-007-3484-x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Jung SH, Kim MS, Jung CK, Park HC, Kim SY, et al. (2016) Mutational burdens and evolutionary ages of thyroid follicular adenoma are comparable to those of follicular adenoma are comparable to those of follicular carcinoma. Oncotarget 7: 69638\u201369648.","DOI":"10.18632\/oncotarget.11922"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/66\/10\/66_EJ19-0035\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T23:42:33Z","timestamp":1572651753000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/66\/10\/66_EJ19-0035\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej19-0035","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736294054.793563409","asserted-by":"object"}]},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}